Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Breath Research

• Publication date

  2016-08-17

• Fields of study

  Medicine, Physics, Environmental Science

• Identifiers
  DOI 10.1088/1752-7155/10/3/036013PMID 27532768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breath concentration of acetic acid vapour is elevated in patients with cystic fibrosis

  2016cited by this paper
• Comparison of sampling bags for the analysis of volatile organic compounds in breath

  2015cited by this paper
• Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls

  2015cited by this paper
• Quantification of phenol in urine headspace using SIFT-MS and investigation of variability with respect to urinary concentration

  2015cited by this paper
• Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis

  2015cited by this paper
• The in vitro identification and quantification of volatile biomarkers released by cystic fibrosis pathogens

  2015cited by this paper
• Inflammatory Bowel Disease

  2015cited by this paper
• Direct detection and quantification of malondialdehyde vapour in humid air using selected ion flow tube mass spectrometry supported by gas chromatography/mass spectrometry.

  2015cited by this paper
• A Specific Breath Metabolome Signature Identifies Patients With Inflammatory Bowel Diseases: 1842

  2015cited by this paper
• Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls

  2015cited by this paper
• Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.

  2015cited by this paper
• Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma

  2015cited by this paper
• Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT–MS quantification of single metabolites

  2015cited by this paper
• Volatile metabolites of pathogens – a Systematic review Plos Pathogens 2013

  2014cited by this paper
• The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis.

  2014cited by this paper
• Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection

  2014cited by this paper
• Reactions of the selected ion flow tube mass spectrometry reagent ions H3O(+) and NO(+) with a series of volatile aldehydes of biogenic significance.

  2014cited by this paper
• Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study

  2014cited by this paper
• Quantification by SIFT-MS of volatile compounds emitted by Aspergillus fumigatus cultures and in co-culture with Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pneumoniae

  2014cited by this paper
• A122: Metabolomic Analysis of Breath Volatile Organic Compounds Reveals Unique Breathprints in Children With Juvenile Idiopathic Arthritis

  2014cited by this paper
• On the importance of statistics in breath analysis—hope or curse?

  2014cited by this paper
• Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection

  2013cited by this paper
• Quantification by SIFT-MS of acetaldehyde released by lung cells in a 3D model.

  2013cited by this paper
• Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.

  2013cited by this paper
• SIFT-MS Analysis of Nose-Exhaled Breath; Mouth Contamination and the Influence of Exercise

  2013cited by this paper
• Volatile Metabolites of Pathogens: A Systematic Review

  2013cited by this paper
• Advances in On-line Absolute Trace Gas Analysis by SIFT-MS

  2013cited by this paper
• Minimising the Effects of Isobaric Product Ions in SIFT-MS Quantification of Acetaldehyde, Dimethyl

  2013cited by this paper
• Quantification of hydrogen cyanide and 2-aminoacetophenone in the headspace of Pseudomonas aeruginos

  2012cited by this paper
• Selected ion flow tube-MS analysis of headspace vapor from gastric content for the diagnosis of gastro-esophageal cancer.

  2012cited by this paper
• Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosa

  2012cited by this paper
• Molecular analysis of methanogenic archaea in the forestomach of the alpaca (Vicugna pacos)

  2012cited by this paper
• Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa

  2012cited by this paper
• An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide

  2012cited by this paper
• Selected ion flow tube, SIFT, studies of the reactions of H3O+, NO+ and O2+ with some biologically active isobaric compounds in preparation for SIFT-MS analyses

  2011cited by this paper
• Breath acetone concentration; biological variability and the influence of diet

  2011cited by this paper
• Pattern differentiation in co-culture biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa.

  2011cited by this paper
• Progress in SIFT-MS: breath analysis and other applications.

  2011cited by this paper
• Ambient analysis of trace compounds in gaseous media by SIFT-MS.

  2011cited by this paper
• Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry.

  2011cited by this paper
• Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7–18 years studied using SIFT-MS

  2010cited by this paper
• Mixed bacterial-fungal infections in the CF respiratory tract.

  2010cited by this paper
• Suitability of different polymer bags for storage of volatile sulphur compounds relevant to breath analysis.

  2009cited by this paper
• Breath gas aldehydes as biomarkers of lung cancer

  2009cited by this paper
• Ionic diffusion and mass discrimination effects in the new generation of short flow tube SIFT-MS instruments

  2009cited by this paper
• Influence of weakly bound adduct ions on breath trace gas analysis by selected ion flow tube mass spectrometry (SIFT-MS)

  2009cited by this paper
• A study of sulfur-containing compounds in mouth- and nose-exhaled breath and in the oral cavity using selected ion flow tube mass spectrometry

  2008cited by this paper
• Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of Detection

  2008cited by this paper
• Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS

  2008cited by this paper
• On the use of Tedlar® bags for breath-gas sampling and analysis

  2008cited by this paper
• A selected ion flow tube mass spectrometry study of ammonia in mouth- and nose-exhaled breath and in the oral cavity.

  2008cited by this paper
• Volatile metabolites in the exhaled breath of healthy volunteers: their levels and distributions

  2007cited by this paper
• The concentration distributions of some metabolites in the exhaled breath of young adults

  2007cited by this paper
• Demonstration of selected ion flow tube MS detection in the parts per trillion range.

  2007cited by this paper
• A general method for the calculation of absolute trace gas concentrations in air and breath from selected ion flow tube mass spectrometry data

  2006cited by this paper
• Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis.

  2005cited by this paper
• Double-layer Tedlar bags: a means to limit humidity evolution of air samples and to dry humid air samples

  2005cited by this paper
• Quantification of hydrogen cyanide in humid air by selected ion flow tube mass spectrometry.

  2004cited by this paper
• Analysis of ketones by selected ion flow tube mass spectrometry.

  2003cited by this paper
• Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry.

  2003cited by this paper
• Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling.

  2001cited by this paper
• Quantification of hydrogen sulphide in humid air by selected ion flow tube mass spectrometry.

  2000cited by this paper
• Quantification of breath isoprene using the selected ion flow tube mass spectrometric analytical method.

  1999cited by this paper
• Quantification of ammonia in human breath by the selected ion flow tube analytical method using H30+ and 02+ precursor ions.

  1998cited by this paper
• SIFT studies of the reactions of H3O+, NO+ and O2+ with a series of alcohols

  1997cited by this paper
• Malondialdehyde determination as index of lipid peroxidation.

  1990cited by this paper
• Trace composition of human respiratory gas.

  1975cited by this paper

• Modeling reciprocal adaptation of Staphylococcus aureus and Pseudomonas aeruginosa co-isolates in artificial sputum medium

  2025cites this paper
• Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy

  2024cites this paper
• Identification of Exhaled Metabolites Correlated with Respiratory Function and Clinical Features in Adult Patients with Cystic Fibrosis by Real-Time Proton Mass Spectrometry

  2024cites this paper
• Untargeted metabolomics unveiled the role of butanoate metabolism in the development of Pseudomonas aeruginosa hypoxic biofilm

  2024cites this paper
• The Respiratory Microbiome in Paediatric Chronic Wet Cough: What Is Known and Future Directions

  2023cites this paper
• The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis

  2022cites this paper
• Volatile Organic Compounds Emitted by Biological Matrices

  2022cites this paper
• Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study

  2022cites this paper
• Mass spectrometry for breath analysis

  2022cites this paper
• Was haben wir aus bisherigen Studien gelernt?

  2021cites this paper
• How Bacterial Adaptation to Cystic Fibrosis Environment Shapes Interactions Between Pseudomonas aeruginosa and Staphylococcus aureus

  2021cites this paper
• Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.

  2020cites this paper
• Trophic cooperation promotes bacterial survival of Staphylococcus aureus and Pseudomonas aeruginosa

  2020cites this paper
• Proteomics and Metabolomics for Cystic Fibrosis Research

  2020cites this paper
• Selected ion flow tube mass spectrometry

  2020cites this paper
• Breath analysis in respiratory diseases: state-of-the-art and future perspectives

  2019cites this paper
• Breathprinting-Based Diagnosis: Case Study: Respiratory Diseases

  2019cites this paper
• Machine learning for the meta-analyses of microbial pathogens’ volatile signatures

  2018cites this paper
• A detailed study of the ion chemistry of alkenes focusing on heptenes aimed at their SIFT-MS quantification

  2018cites this paper
• On the importance of accurate quantification of individual volatile metabolites in exhaled breath

  2017cites this paper
• Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations

  2017cites this paper
• Acetic acid is elevated in the exhaled breath of cystic fibrosis patients.

  2017cites this paper
• Mass spectrometric techniques for the analysis of volatile organic compounds emitted from bacteria.

  2017cites this paper